Paper26608331
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Marty C and 11 others. Blood, 2016. Cited by 229 papers, by iCite.
Cite this record
ConductScience Library. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Papers, record 26608331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26608331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calreticulin | Major topic |
| INDEL Mutation | Major topic |
| Megakaryocytes | Major topic |
| Primary Myelofibrosis | Major topic |
| Receptors, Thrombopoietin | Major topic |
| Thrombocytosis | Major topic |
| Animals | |
| Frameshift Mutation | |
| Janus Kinase 2 | |
| Mice | |
| Mice, Mutant Strains |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26965919 | Mutant calreticulin: when a chaperone becomes intrusive. | https://conductscience.org/library/papers/26965919 |
Source PubMed
Cited by156
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42956057 | Molecular and functional analysis of calcium binding by a cancer-linked calreticulin mutant. | Elife | 2026 | https://conductscience.org/library/papers/42956057 | PubMed |
| 42811375 | Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications. | Biomark Res | 2026 | https://conductscience.org/library/papers/42811375 | PubMed |
| 42806053 | PIM1 in myeloproliferative neoplasms: potential pathogenic and therapeutic implications. | Leukemia | 2026 | https://conductscience.org/library/papers/42806053 | PubMed |
| 42786200 | Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling. | Leukemia | 2026 | https://conductscience.org/library/papers/42786200 | PubMed |
| 42745000 | Type 1 interferon perturbates clonal competition by reshaping human blood development. | Nat Genet | 2026 | https://conductscience.org/library/papers/42745000 | PubMed |
| 42689321 | Targeting Thrombopoietin/MPL Signaling to Mitigate JAK2V617F-Driven Cardiac Microvascular Disease. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/42689321 | PubMed |
| 42613432 | Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms. | Leukemia | 2026 | https://conductscience.org/library/papers/42613432 | PubMed |
| 42346284 | Frequency of Non-Type I/II CALR Mutations in Patients Undergoing Molecular Diagnostics for Myeloproliferative Neoplasms. | Diseases | 2026 | https://conductscience.org/library/papers/42346284 | PubMed |
| 42131291 | CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment. | Hemasphere | 2026 | https://conductscience.org/library/papers/42131291 | PubMed |
| 41971416 | Plasma cfDNA and peripheral blood gDNA provide complementary information for molecular monitoring in myeloproliferative neoplasms. | Front Oncol | 2026 | https://conductscience.org/library/papers/41971416 | PubMed |
| 41959476 | Targeting TPO/MPL Signaling to Mitigate JAK2V617F-driven Cardiac Microvascular Disease. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959476 | PubMed |
| 41798678 | Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasms. | Blood Neoplasia | 2026 | https://conductscience.org/library/papers/41798678 | PubMed |
| 41532194 | A Murine Bispecific Antibody Efficiently Redirects T Cells Against Calr Mutated Stem Cells In Vivo. | Am J Hematol | 2026 | https://conductscience.org/library/papers/41532194 | PubMed |
| 41268701 | Sabotaged Integral HSC Heterogeneity Underlies Essential Thrombocythemia Development. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41268701 | PubMed |
| 40857671 | Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis. | Blood | 2026 | https://conductscience.org/library/papers/40857671 | PubMed |
| 40623967 | JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms. | Nat Commun | 2025 | https://conductscience.org/library/papers/40623967 | PubMed |
| 40619749 | JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40619749 | PubMed |
| 40586641 | CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation. | Cell Biol Int | 2025 | https://conductscience.org/library/papers/40586641 | PubMed |
| 40403318 | Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms. | Blood | 2025 | https://conductscience.org/library/papers/40403318 | PubMed |
| 40355863 | Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40355863 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALR | 811 | PubTator's text mining | https://conductscience.org/library/genes/811 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26608331
GET https://conductscience.org/api/papers/v1/26608331/cited_by?page=2